Co-Diagnostics (CODX) Competitor Comparison
We are evaluating the key criteria listed to compare Co-Diagnostics (CODX) against its competitors in the Diagnostics & Research industry.
Market Capitalization
51 / 58Gross Profits
41 / 52Total Revenue
52 / 57EBITDA
44 / 56Free Cashflow
37 / 56Quick Ratio
2 / 57Earnings per Share
38 / 56Dividend yield
0 / 9Total Cash
39 / 57Performance 3 years
50 / 58Performance 5 years
25 / 58Performance 10 years
45 / 58Linearity 3 years
50 / 58Linearity 5 years
2 / 58Linearity 10 years
19 / 58Total Rank
39 / 58Dividend Rank
45 / 58Valuation Rank
31 / 58Piotroski Rank
39 / 58Muliplier Rank
42 / 58Market Capitalization - CODX ranking 51 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.